Histone cluster 1 H4L Inhibitors
Histone cluster 1 H4L Inhibitors belong to a specialized class of chemical compounds designed to selectively inhibit the activity of histone cluster 1, with a specific emphasis on the H4L subtype. Histones play a pivotal role in the organization of DNA within the nucleus, forming nucleosomes that serve as the structural foundation for chromatin. The H4L designation refers to a variant of histone H4, one of the core histones essential for nucleosome assembly. As a specific variant within histone cluster 1, H4L becomes a focal point for researchers seeking to unravel the complexities of chromatin dynamics and gene regulation.
The development of Histone cluster 1 H4L Inhibitors necessitates a comprehensive understanding of the structural characteristics of histone H4L and its specific role within chromatin organization. These inhibitors are meticulously crafted for specificity, aiming to selectively bind to key regions of Histone cluster 1 H4L and disrupt its normal functions. By employing these inhibitors in experimental contexts, researchers can explore the consequences of inhibiting this particular histone variant, providing valuable insights into chromatin remodeling and the intricate regulation of gene expression. The study of histones, including variants like H4L, significantly contributes to advancing our understanding of epigenetic mechanisms, offering crucial insights into the dynamic processes governing gene regulation and the complex orchestration of cellular functions at the chromatin level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ITF2357 | 732302-99-7 | sc-364513 sc-364513A | 5 mg 50 mg | $340.00 $1950.00 | ||
Givinostat is an HDAC inhibitor that can increase acetylation levels of histones, potentially altering the expression of various genes, including those coding for histones. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin is a cyclic peptide HDAC inhibitor that alters acetylation patterns of histones, which may affect gene expression, including histone genes. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $64.00 $183.00 | 11 | |
Scriptaid is an HDAC inhibitor that can lead to changes in chromatin structure and gene expression by altering histone acetylation levels, potentially affecting histone gene expression. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat is an HDAC inhibitor that may modify acetylation patterns and thereby influence the expression of genes, including those for histones. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat is an HDAC inhibitor that could lead to hyperacetylation of histones and thus potentially alter the transcription of histone genes. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $62.00 $250.00 $1196.00 | ||
Chidamide is a benzamide HDAC inhibitor that may alter histone acetylation, potentially affecting gene expression, including that of histone genes. | ||||||
CI 994 | 112522-64-2 | sc-205245 sc-205245A | 10 mg 50 mg | $99.00 $536.00 | 1 | |
Tacedinaline is an HDAC inhibitor that could change the acetylation status of histones and affect gene expression, potentially including histone genes. | ||||||